Order, please.
I would like to welcome the witnesses who are here today.
What we're going to do is listen to the witnesses, but before we actually hear from the witnesses, I want to remind members that we will be discussing committee business in camera, beginning at 12:30. We will go in camera at that time for discussions.
The witnesses have heard this as well. At 12:30 we will ask you to leave the room so we can go into our business.
We really want to welcome you. We feel very privileged to have you in front of the committee today, and pursuant to Standing Order 108, I'd like to welcome you to the eighth meeting on post-market surveillance of pharmaceutical products.
You know, members, that our panel today consists of representatives from the Anemia Institute for Research and Education, the Consumers' Association of Canada, and PharmaWatch.
Just to get started, I would like to remind the witnesses that witnesses have 10 minutes per organization to make their presentation. What will happen is that the committee will hear all presentations first before proceeding to the members.
Let us begin with Ms. Durhane Wong-Rieger.